block randomisation (STATA Corporation)
STATA Corporation is a verified supplier 
90
Structured Review
STATA Corporation
block randomisation
Block Randomisation, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/block+randomisation/block+randomisation/pmc12173124-99-5-12
Average 90 stars, based on 1 article reviews
Block Randomisation, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/block+randomisation/block+randomisation/pmc12173124-99-5-12
Average 90 stars, based on 1 article reviews
block randomisation - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "Investigating the effectiveness of an intraoperative decision support guided fluid therapy intervention on postoperative outcome of high-risk patients undergoing high-risk abdominal surgery: protocol for an international multicentre stepped-wedge cluster-randomised implementation trial"
Article Title: Investigating the effectiveness of an intraoperative decision support guided fluid therapy intervention on postoperative outcome of high-risk patients undergoing high-risk abdominal surgery: protocol for an international multicentre stepped-wedge cluster-randomised implementation trial
Journal: BJA Open
doi: 10.1016/j.bjao.2025.100421
Figure Legend Snippet: Stepped-wedge study design of the PEFLA trial. Considering the number of participating centres (16 centres) and the duration of this study (24 months), it was proposed to fix eight intervals of 3 months each. The randomisation will involve seven steps, each of them including two to three centres.
Techniques Used:
Related Articles
Blocking Assay:Article Title: Using a cash transfer plus SMS nudge package to improve the wellbeing among caregivers of adolescents living with HIV during the COVID-19 epidemic in South Africa: A pilot randomised controlled trial. Article Snippet: .. A statistician (LS) masked to Article Title: Transauricular nerve stimulation in acute ischaemic stroke requiring mechanical thrombectomy: Protocol for a phase 2A, proof-of-concept, sham-controlled randomised trial. Article Snippet: .. Article Title: Investigating the effectiveness of an intraoperative decision support guided fluid therapy intervention on postoperative outcome of high-risk patients undergoing high-risk abdominal surgery: protocol for an international multicentre stepped-wedge cluster-randomised implementation trial Article Snippet: .. Article Title: The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): a double-blind randomised placebo-controlled trial. Article Snippet: .. Allocations were computer generated using Article Title: Rivastigmine for Alzheimer's disease Article Snippet: .. Behavioral symptoms Cohen‐Mansfield Agitation Inventory (CMAI) Patients were evaluated at 6, 12 and 26 weeks Source of funding Alzheimer's Research Trust, general donation to the main investigator's (Clive Ballard) research programme and profits from previously completed commercial trials Declaration of interest Main investigator has received honoraria and research donations to support this research programme from Novartis and Astra Zeneca (manufacturers) Notes Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk "Computer generated with Sequencing:Article Title: Investigating the effectiveness of an intraoperative decision support guided fluid therapy intervention on postoperative outcome of high-risk patients undergoing high-risk abdominal surgery: protocol for an international multicentre stepped-wedge cluster-randomised implementation trial Article Snippet: .. Article Title: Rivastigmine for Alzheimer's disease Article Snippet: .. Behavioral symptoms Cohen‐Mansfield Agitation Inventory (CMAI) Patients were evaluated at 6, 12 and 26 weeks Source of funding Alzheimer's Research Trust, general donation to the main investigator's (Clive Ballard) research programme and profits from previously completed commercial trials Declaration of interest Main investigator has received honoraria and research donations to support this research programme from Novartis and Astra Zeneca (manufacturers) Notes Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk "Computer generated with Generated:Article Title: Investigating the effectiveness of an intraoperative decision support guided fluid therapy intervention on postoperative outcome of high-risk patients undergoing high-risk abdominal surgery: protocol for an international multicentre stepped-wedge cluster-randomised implementation trial Article Snippet: .. Article Title: The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): a double-blind randomised placebo-controlled trial. Article Snippet: .. Allocations were computer generated using Article Title: Rivastigmine for Alzheimer's disease Article Snippet: .. Behavioral symptoms Cohen‐Mansfield Agitation Inventory (CMAI) Patients were evaluated at 6, 12 and 26 weeks Source of funding Alzheimer's Research Trust, general donation to the main investigator's (Clive Ballard) research programme and profits from previously completed commercial trials Declaration of interest Main investigator has received honoraria and research donations to support this research programme from Novartis and Astra Zeneca (manufacturers) Notes Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk "Computer generated with other:Article Title: Heart rate variability in pulmonary vascular disease at altitude: a randomised trial Article Snippet: Selection:Article Title: Rivastigmine for Alzheimer's disease Article Snippet: .. Behavioral symptoms Cohen‐Mansfield Agitation Inventory (CMAI) Patients were evaluated at 6, 12 and 26 weeks Source of funding Alzheimer's Research Trust, general donation to the main investigator's (Clive Ballard) research programme and profits from previously completed commercial trials Declaration of interest Main investigator has received honoraria and research donations to support this research programme from Novartis and Astra Zeneca (manufacturers) Notes Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk "Computer generated with |